Lupin launches Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03 per cent and 0.06 per cent in…
The medication is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennial rhinitis…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Endometriosis market to grow to $2.5 bn across 7MM in 2034
GlobalData’s latest report reveals that the strong growth of the endometriosis market will be primarily fueled by the introduction…
Funding declines in pharma as June sees 97% plunge
Total funding reached $7.2 million across 5 rounds, representing a 97.07 per cent decrease from May 2025
Parexel appoints two FDA luminaries, Dr Lola Fashoyin-Aje, and Dr Tala Fakhouri to its Consulting…
These strategic appointments will bolster the company’s regulatory expertise
EU approves Biocon Biologics’ Denosumab biosimilars
Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (Receptor Activator of Nuclear Factor…
Vaccine sales plummet in China, posing a challenge for big pharma: GlobalData
GlobalData attributes this drop to price competition from local manufacturers and China’s ongoing anti-corruption crackdown on the…
Nymi, Caliber Technologies partner to enable Passwordless Authentication in Pharma Manufacturing
This collaboration aims to strengthen MES, LIMS, and QMS automation by reducing manual logins and streamlining electronic…
Pharmexcil reports robust exports: $ 2,475.70 mn in May 2025, Cumulating to $ 4,961.71 mn for…
According to the reports, a 7.38 per cent expansion was observed compared to May 2024-25
Asahi Kasei Pharma starts Phase III study of CIPN prevention therapy
Previous Phase I and II studies suggest efficacy and patient tolerability of ART-123 for CIPN by suppressing the activation of…
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country
Durvalumab in combination with carboplatin and paclitaxel is now also indicated for first-line treatment of adults with primary…